BDBM420298 CVD-0006356::PF-00835231::PF-0835231::US11524940, Compound 741::US11753373, Compound A-5-d::US12077605, Compound PF-00835231::WO2005113580-Ex-02::WO2021205298, Compound 1::cmdc.202100576, 6b

SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO

InChI Key InChIKey=QDIMHKWNHMVDJB-UHFFFAOYSA-N

Data  29 KI  25 IC50  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 420298   

TargetReplicase polyprotein 1a(2019-nCoV)
Anixa Biosciences

US Patent
LigandPNGBDBM420298(WO2005113580-Ex-02 | PF-00835231 | PF-0835231 | cm...)
Affinity DataIC50: 65nMAssay Description:Representative Compounds of the Disclosure, PF-00835231, and PF-07321332 were tested for their capability to inhibit the SARS-CoV-2 main protease Mpr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
Go to US Patent